By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS








Company News
CytRx Corporation (CYTR) Initiates Global Phase 2b Clinical Trial Of Aldoxorubicin For The Treatment Of Relapsed/Refractory Small Cell Lung Cancer 9/30/2014 8:07:55 AM
CytRx Corporation (CYTR) Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer 9/29/2014 8:55:44 AM
CytRx Corporation (CYTR) Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas And Global Phase 2b Small Cell Lung Cancer Trial Designs At ESMO 2014 Congress 9/22/2014 7:34:00 AM
CytRx Corporation (CYTR) To Present At Biocentury's 2014 Newsmakers In The Biotech Industry Conference 9/19/2014 7:59:30 AM
CytRx Corporation (CYTR) Updates Presentation Time At Biocentury's 2014 Newsmakers In The Biotech Industry Conference 9/18/2014 10:45:54 AM
CytRx Corporation (CYTR) Initiates Phase 1b Clinical Trial With Combination Of Aldoxorubicin And Ifosfamide/Mesna As First-Line Treatment In Patients With Advanced Sarcomas 9/9/2014 10:58:14 AM
CytRx Corporation (CYTR) Updates Presentation Time At Aegis 2014 Healthcare & Technology Conference 9/5/2014 11:08:57 AM
CytRx Corporation (CYTR) To Present At Upcoming Investor Conferences In New York City And Las Vegas 9/2/2014 1:51:08 PM
Oral Presentation Of CytRx Corporation (CYTR)’s Aldoxorubicin Phase 2b Clinical Trial In Soft Tissue Sarcoma Highlighted In The Lancet Oncology 8/7/2014 10:06:35 AM
CytRx Corporation (CYTR) Reports 2014 Second Quarter Financial Results 8/6/2014 9:21:07 AM
12345678910...
//-->